Inclusion Criteria:  Subject and/or legally authorized representative has reviewed the IRB- approved consent form, has been properly consented per the protocol and has documented their consent to participate in the study by signing the IRB-approved consent form. Subject is ≥ 18 years of age at the time of consent. Subjects with intraventricular hemorrhage (spontaneous primary IVH or secondary IVH due to ruptured aneurysm) who have had CerebroFlo™ EVD Catheter(s) placed without complication. Subjects who require only one EVD Catheter at initial admission  Exclusion Criteria:  Subjects with a scalp infection present. Subjects with uncorrectable coagulopathy due to prior administration of anticoagulants at the time the CerebroFlo™ EVD Catheter(s) is placed. Subjects known to have a bleeding diathesis. Subjects in which the CerebroFlo™ EVD Catheter(s) is placed directly into a hematoma Evidence of catheter-associated hemorrhage from insertion of the CerebroFlo EVD Catheter(s) on post-placement CT scan. Subject is pregnant